MaraƱon, Araceli G.
HRN: 23 71 82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/20/2023
09/26/2023
Q6
4.5gm
Q6
Septicemia
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes